产品封面图
文献支持

Recombinant FHV-1 glycoprotein

E/gE Protein, C-Fc
收藏
  • ¥1868
  • abinScience
  • France
  • VK031011
  • 2025年08月13日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

    • 保质期

      1 year

    • 英文名

      Recombinant FHV-1 glycoprotein E/gE Protein, C-Fc

    • 库存

      999

    • 供应商

      abinScience

    • 规格

      100ug

    产品细节图片1

    Product nameRecombinant FHV-1 glycoprotein E/gE Protein, C-Fc
    Catalog No.VK031011
    FormLyophilized
    Storage bufferLyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
    Purity>90% as determined by SDS-PAGE.
    ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
    Endotoxin levelPlease contact with the lab for this information.
    Expression systemMammalian Cells
    AccessionYP_003331591.1
    ReconstitutionReconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
    Alternative Namesenvelope glycoprotein E, US8
    SpeciesFelid alphaherpesvirus 1
    ShippingIn general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

    abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.

     

    Technology and Innovation

    Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003...

     

    Product categories and application fields.

    Main products...
    Application field: Infectious disease research, Neuroscience, Immunology, Oncology

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    • Herpes Zoster Vaccines., PMID:34590136
    • Rational optimization of glycoprotein E (gE)-encoding mRNA for improved Varicella-zoster virus mRNA vaccine development., PMID:39137287
    • Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older., PMID:29529222
    • Varicella zoster virus glycoprotein E facilitates PINK1/Parkin-mediated mitophagy to evade STING and MAVS-mediated antiviral innate immunity., PMID:38184594
    • The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70., PMID:34283213
    • The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy., PMID:38037900
    Alphaherpesvirus glycoprotein E: A review of its interactions with other proteins of the virus and its application in vaccinology., PMID:35992696
    • Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus., PMID:39337359
    • Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial., PMID:30707761
    • Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial., PMID:30843046
    相关实验
    • Monitoring Recombinant Glycoprotein Heterogeneity

      recombinant protein in vivo (1 ). Glycosylation is the most extensive source of protein heterogeneity, and many recent developments in analytical biotechnology have enhanced the ability to monitor and structurally define changes in oligosaccharides associated

    • 【原创】Protein A Sepharose 之进化篇。。。

      洗脱条件比较剧烈,最后收集的蛋白质很有可能变性,或者是复性困难。 这种洗脱条件剧烈的Protein A 柱结合的重组蛋白质A一般具有5个串联结构域:E、D、A、B、C。这种重组蛋白A虽然除去了不重要的非结合域,仅由5个结构域组成,每个域均可以和IgG的Fc段结合,但不同的域结合强度略有差异。因此洗脱条件不均一,而且经常需要较低的pH值。如果减少串联结构域的个数,并且采取同型结构域串联,就可以避免不同结构域与抗体Fc 段亲和性的差异,洗脱条件会温和而均一。为此,我们可以做一个试验,比较一下

    • Combined 3C-ChIP-Cloning (6C) Assay: A Tool to Unravel Protein-Mediated Genome Architecture

      to 37°C and 65°C Sonicator Spectrophotometer Thermal cycler, automated Timer Tubes, microcentrifuge, 1.5-mL Tubes, polypropylene, 14-mL (e.g., 17- x 100-mm) for use in high-speed centrifuge Tubes, polypropylene, 50-mL

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1868
    普健生物(武汉)科技有限公司
    2025年08月13日询价
    ¥13734
    武汉华美生物工程有限公司CUSABIO®
    2025年07月11日询价
    ¥1600
    武汉益普生物科技有限公司
    2025年12月06日询价
    ¥12965
    澳培赛生物科技(上海)有限公司
    2025年12月23日询价
    ¥5586
    MedChemExpress LLC
    2025年12月05日询价
    文献支持
    Recombinant FHV-1 glycoprotein E/gE Protein, C-Fc
    ¥1868